Daily non-political popular news in brief.

Diuretics comparable to or better than other hypertension drugs in patients with metabolic syndrome

Use of calcium-channel blockers, alpha-blockers or angiotensin-converting enzyme inhibitors appears to offer no advantages in improving clinical outcomes compared with use of diuretics when treating hypertension among individuals with metabolic syndrome, according to a report in the Jan. 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. This appears particularly true for black patients.

Read more »

Keywords: diuretics, comparable, hypertension, drugs, patients, metabolic, syndrome, diuretic, drug, patient

« Previous | Next »

Similar news on "Diuretics comparable to or better than other hypertension drugs in patients with metabolic syndrome":

1. Diuretics excel in drug comparison trial involving hypertension/metabolic syndrome
   01-28-2008 · EurekAlert!
   Diuretics were associated with reduced heart disease in a drug comparison trial involving 23,077 people with both high blood pressure and the metabolic syndrome, a cluster of risk factors for heart disease, report researchers from the University of Texas School of Public Health and Case Western Reserve University in the Jan. 28 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.
   Similar news · Read more »
   
2. Hepatitis B drug can compromise HIV treatment
   06-20-2007 · EurekAlert!
   Treating hepatitis B patients with the drug entecavir can cause those who are also infected with HIV to become resistant to two of the most important drugs in the anti-HIV arsenal. In findings published in the New England Journal of Medicine, researchers reported that a patient infected with both hepatitis B and HIV who was treated with entecavir developed a mutant strain of HIV that is resistant to the antiviral drugs lamivudine and emtricitabine.
   Similar news · Read more »
   
3. Mouse Tests Predict Drug Response In Relapsing Pancreatic Cancer Patients
   10-12-2006 · ScienceDaily
   By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately 'test drive' chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
   Similar news · Read more »
   
4. For treating malaria, less drugs may be best drugs
   11-26-2007 · EurekAlert!
   The current dosage of drugs used in treating malaria may be helping the parasites become resistant to the drugs faster, without improving the long-term outcome in patients. According to evolutionary biologists, studies using mice suggest that the optimal use of the drugs might slow the spread of drug resistance while making the patient just as healthy.
   Similar news · Read more »
   
5. Patients can't recall their medications to tell doctors
   10-11-2007 · EurekAlert!
   Doctors depend on patients to accurately tell them what drugs they are taking in out-patient visits. But Northwestern University found nearly 50 percent of patients taking antihypertensive drugs were unable to accurately name a single one of their medications. Thus, doctors can't monitor if a drug is working or know about potential adverse interactions.
   Similar news · Read more »
   
6. Mouse tests predict drug response in relapsing pancreatic cancer patients
   10-11-2006 · EurekAlert!
   By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately "test drive" chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
   Similar news · Read more »
   
7. Annals of Internal Medicine tip sheet for March 20, 2007
   03-19-2007 · EurekAlert!
   The following articles are featured in the upcoming Annals of Internal Medicine: "Flexible Use of Drugs with Close Patient Follow-up Can Successfully Control Rheumatoid Arthritis;" "Osteoporosis Drug Strengthens Bones in Men with Prostate Cancer," and "Experts Show Physicians How to Initiate and Carry Through Timely and Effective Discussions about Hospice with Dying Patients."
   Similar news · Read more »
   
8. Implant device effectively maintains heart function for transplant-listed patients
   03-27-2007 · EurekAlert!
   Whether a patient is awaiting a heart transplant or living with chronic heart failure, cardiologists are continuously looking for new therapies that address short-term and/or long-term needs of chronically impaired cardiac patients. Research presented today at the American College of Cardiology's 56th Annual Scientific Session reviewed new treatments and interventions, including LVAD implantation and diuretic therapies to support left ventricular function in severely compromised cardiovascular patients.
   Similar news · Read more »
   
9. Hopkins scientists uncover cause of antipsychotic drug weight gain
   02-12-2007 · EurekAlert!
   Johns Hopkins brain scientists have hit on how and why some powerful drugs used for treating mental illnesses cause patients to gain so much weight that they often develop life-threatening complications such as diabetes and heart disease.
   Similar news · Read more »
   
10. Penn's Abramson Cancer Center part of major phase III study for myeloma
    11-21-2007 · EurekAlert!
    Researchers from the UPenn's Abramson Cancer Center announced today that findings from two international clinical trials show unprecedented survival for patients with myeloma, a cancer the blood-making cells of bone marrow. Findings show that with the oral drug lenalidomide, in combination with dexamethasone, patients significantly improved by all measures where previous treatments had failed -- including a median survival of nearly three years -- the longest median survival known for this difficult to treat patient group.
    Similar news · Read more »